158 related articles for article (PubMed ID: 25801885)
1. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage.
Dolcino M; Puccetti A; Barbieri A; Bason C; Tinazzi E; Ottria A; Patuzzo G; Martinelli N; Lunardi C
Lupus; 2015 Apr; 24(4-5):419-32. PubMed ID: 25801885
[TBL] [Abstract][Full Text] [Related]
2. Induction of endothelial cell damage by hCMV molecular mimicry.
Lunardi C; Bason C; Corrocher R; Puccetti A
Trends Immunol; 2005 Jan; 26(1):19-24. PubMed ID: 15629405
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.
Chang M; Pan MR; Chen DY; Lan JL
Clin Exp Immunol; 2006 Jan; 143(1):167-79. PubMed ID: 16367948
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus and autoimmune disease.
Halenius A; Hengel H
Biomed Res Int; 2014; 2014():472978. PubMed ID: 24967373
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis and infections.
Randone SB; Guiducci S; Cerinic MM
Autoimmun Rev; 2008 Oct; 8(1):36-40. PubMed ID: 18706530
[TBL] [Abstract][Full Text] [Related]
7. B cell epitope of human cytomegalovirus phosphoprotein 65 (HCMV pp65) induced anti-dsDNA antibody in BALB/c mice.
HoHsieh A; Wang CM; Wu YJ; Chen A; Chang MI; Chen JY
Arthritis Res Ther; 2017 Mar; 19(1):65. PubMed ID: 28320458
[TBL] [Abstract][Full Text] [Related]
8. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.
Lunardi C; Bason C; Navone R; Millo E; Damonte G; Corrocher R; Puccetti A
Nat Med; 2000 Oct; 6(10):1183-6. PubMed ID: 11017152
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to human cytomegalovirus protein UL83 in systemic sclerosis.
Namboodiri AM; Rocca KM; Kuwana M; Pandey JP
Clin Exp Rheumatol; 2006; 24(2):176-8. PubMed ID: 16762154
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a human antibody that potentially links cytomegalovirus infection with systemic lupus erythematosus.
Neo JYJ; Wee SYK; Bonne I; Tay SH; Raida M; Jovanovic V; Fairhurst AM; Lu J; Hanson BJ; MacAry PA
Sci Rep; 2019 Jul; 9(1):9998. PubMed ID: 31292492
[TBL] [Abstract][Full Text] [Related]
11. The microvascular endothelium in scleroderma.
Kahaleh B
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v14-5. PubMed ID: 18784128
[TBL] [Abstract][Full Text] [Related]
12. Human Cytomegalovirus and Autoimmune Diseases: Where Are We?
Gugliesi F; Pasquero S; Griffante G; Scutera S; Albano C; Pacheco SFC; Riva G; Dell'Oste V; Biolatti M
Viruses; 2021 Feb; 13(2):. PubMed ID: 33567734
[TBL] [Abstract][Full Text] [Related]
13. A novel pattern of pp65-positive cytomegalic endothelial cells circulating in peripheral blood from a renal transplant recipient.
Ye Q; Luo G; He X; Zheng L; Dong X; Xu X; Gao J; Nilsson-Ehle P; Xu N
Acta Histochem; 2004; 106(2):107-10. PubMed ID: 15147631
[TBL] [Abstract][Full Text] [Related]
14. Role of viral infections in the etiopathogenesis of systemic sclerosis.
Moroncini G; Mori S; Tonnini C; Gabrielli A
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):3-7. PubMed ID: 23910606
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus targets different subsets of antigen-presenting cells with pathological consequences for host immunity: implications for immunosuppression, chronic inflammation and autoimmunity.
Varani S; Frascaroli G; Landini MP; Söderberg-Nauclér C
Rev Med Virol; 2009 May; 19(3):131-45. PubMed ID: 19367559
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cells' activation and apoptosis induced by a subset of antibodies against human cytomegalovirus: relevance to the pathogenesis of atherosclerosis.
Lunardi C; Dolcino M; Peterlana D; Bason C; Navone R; Tamassia N; Tinazzi E; Beri R; Corrocher R; Puccetti A
PLoS One; 2007 May; 2(5):e473. PubMed ID: 17534423
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of human cytomegalovirus infection and cellular targets.
Gerna G; Baldanti F; Revello MG
Hum Immunol; 2004 May; 65(5):381-6. PubMed ID: 15172435
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.
Marou E; Liaskos C; Simopoulou T; Efthymiou G; Dardiotis E; Katsiari C; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Rheumatol; 2017 Apr; 36(4):863-869. PubMed ID: 28124759
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus infection and atherothrombosis.
Popović M; Smiljanić K; Dobutović B; Syrovets T; Simmet T; Isenović ER
J Thromb Thrombolysis; 2012 Feb; 33(2):160-72. PubMed ID: 22161772
[TBL] [Abstract][Full Text] [Related]
20. Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis.
Marou E; Liaskos C; Efthymiou G; Dardiotis E; Daponte A; Scheper T; Meyer W; Hadjigeorgiou G; Bogdanos DP; Sakkas LI
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):31-34. PubMed ID: 28240591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
